Identification, characterization and quantification of specific neuropeptides in rat spinal cord by liquid chromatography electrospray quadrupole ion trap mass spectrometry

Biomedical Chromatography - Tập 23 Số 9 - Trang 940-950 - 2009
Francis Beaudry1, Catherine E. Ferland1, Pascal Vachon1
1Department of Veterinary Biomedicine, Faculty of Veterinary Medicine, University of Montreal, Saint-Hyacinthe, Québec, Canada

Tóm tắt

AbstractSubstance P and CGRP play a central role in neuropathic pain development and maintenance. Additionally, dynorphin A is an endogenous ligand of opioid receptors implicated in the modulation of neurotransmitters including neuropeptides, such as substance P and CGRP. This manuscript proposes a method to characterize, identify and quantify substance P, CGRP and dynorphin A in rat spinal cord by HPLC‐ESI/MS/MS. Rat spinal cords were collected and homogenized into a TFA solution. Samples were chromatographed using a microbore C8 100 × 1 mm column and a 19 min linear gradient (0:100 → 40:60; ACN:0.2% formic acid in water) at a flow rate of 75 µL/min for a total run time of 32 min. The peptides were identified in rat spinal cord based on full‐scan MS/MS spectra. Substance P, CGRP and dynorphin A were predominantly identified by the presence of specific b CID fragments. Extracted ion chromatogram (XIC) suggested selected mass transitions of 674 → [600 + 254], 952 → [1215 + 963] and 717 → [944 + 630] for substance P, CGRP and dynorphin A can be used for isolation and quantitative analysis. A linear regression (weighted 1/x) was used and coefficients of correlations (r) ranging from 0.990 to 0.999 were observed. The precision (%CV) and accuracy (%NOM) observed were 10.9–14.4% and 8.9–14.2%, 8.8–13.0% and 91.0–110.2% and 97.2–107.3% and 91.8–97.3% for substance P, CGRP and dynorphin A respectively. Following the analysis of rat spinal cords, the mean endogenous concentrations were 110.7, 2541 and 779.4 pmol/g for substance P, CGRP and dynorphin A respectively. The results obtained show that the method provides adequate figures of merit to support targeted peptidomic studies aimed to determine neuropeptide regulation in animal neuropathic and chronic pain models. Copyright © 2009 John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1016/S0306-4522(01)00134-8

10.1523/JNEUROSCI.18-22-09294.1998

10.1002/cne.901840208

10.1002/bmc.703

Beaudry F, 2007, Early dexamethasone treatment following sciatic nerve cuff implantation decreases substance P in lumbar spinal cord of rats with neuropathic pain, Canadian Journal of Veterinary Research, 71, 90

Beaulieu P., 2005, Pharmacologie de la douleur, 593

10.1021/ac051495j

10.1016/j.jchromb.2003.09.004

10.1007/s10540-005-2851-3

10.1093/bfgp/eli002

10.1126/science.6120570

10.1016/j.aca.2008.06.017

10.1016/0304-3940(88)90395-3

10.1073/pnas.82.12.4291

10.1016/j.jchromb.2007.01.009

10.1038/nature06525

10.1016/0024-3205(92)90045-Q

10.1146/annurev.pa.36.040196.001345

10.1016/S0361-9230(98)00159-2

10.1007/s10540-005-2849-x

10.1046/j.1460-9568.1999.00503.x

10.1016/0306-4522(76)90008-7

10.1002/mas.10050

10.1016/j.aca.2007.07.046

10.1016/0196-9781(90)90187-A

10.1093/bfgp/ell023

10.1016/S1359-6446(05)03620-2

10.1016/0304-3940(88)90611-8

10.1016/S0304-3959(00)00243-8

10.1016/S0304-3959(99)00085-8

10.1073/pnas.85.2.622

SiddallPJ. Management of neuropathic pain following spinal cord injury: now and in the future.Spinal Cord2008;1–8(published online November 11 2008).

10.1089/neu.1998.15.485

Vachon P, 2004, Substance P and neurotensin are up‐regulated in the lumbar spinal cord of animals with neuropathic pain, Canadian Journal of Veterinary Research, 68, 86

10.1016/0306-4522(89)90031-6

Wood PL, 2005, The NMDA receptor complex: a long and winding road to therapeutics, IDrugs, 8, 229

10.1038/286155a0

10.1016/0024-3205(91)90637-Q

Zoorob RJ, 1998, A different look at corticosteroids, American Family Physician, 58, 443

Thông tin
Thông tin xuất bản

Biomedical Chromatography

Tập 23 Số 9

940-950

Thông tin tác giả